Astrazeneca Pharma India standalone net profit declines 98.53% in the March 2016 quarter

Sales rise 10.52% to Rs 133.51 crore

Net profit of Astrazeneca Pharma India declined 98.53% to Rs 0.56 crore in the quarter ended March 2016 as against Rs 38.13 crore during the previous quarter ended March 2015. Sales rose 10.52% to Rs 133.51 crore in the quarter ended March 2016 as against Rs 120.80 crore during the previous quarter ended March 2015.

For the full year,net profit reported to Rs 5.26 crore in the year ended March 2016 as against net loss of Rs 20.84 crore during the previous year ended March 2015. Sales rose 12.24% to Rs 526.46 crore in the year ended March 2016 as against Rs 469.05 crore during the previous year ended March 2015.

ParticularsQuarter EndedYear EndedMar. 2016Mar. 2015% Var.Mar. 2016Mar. 2015% Var.Sales133.51120.80 11 526.46469.05 12 OPM %2.4033.77 -3.12-2.43 - PBDT5.3042.15 -87 23.19-5.56 LP PBT1.0638.13 -97 5.76-20.84 LP NP0.5638.13 -99 5.26-20.84 LP

Powered by Capital Market - Live News